FDA Adverse Event Malfunction Summary report: N

BRAVO PH RECDR

MDR report key: 6010768 · Received October 7, 2016

Report

Report Number
9710107-2016-01038
Event Type
Malfunction
Date Received
October 7, 2016
Report Date
April 11, 2018
Manufacturer
GIVEN LTD (ISRAEL)
Product Code
FFT
PMA / PMN Number
K102543
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: THOUGH THE RECORDER WAS NOT RECEIVED FOR EVALUATION, THE STUDY WAS PROVIDED FOR REVIEW. BASED ON THE DATA THAT WAS COLLECTED DURING THE PROCEDURE, THE STUDY WAS 30:58:42 OF AN ANTICIPATED 48 OR 96 HOURS. PH VALUES ARE NORMAL THROUGHOUT THE DURATION OF THE STUDY. DUE TO THE FACT THAT THE RECORDER WAS NOT RETURNED AND ONLY THE STUDY WAS PROVIDED, THE CAUSE OF THE SHORT STUDY COULD NOT BE RELIABLY DETERMINED. A REVIEW OF THE DEVICE HISTORY RECORD INDICATES THAT THE PRODUCT WAS RELEASED MEETING FINISHED PRODUCT SPECIFICATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE REPORTER, DURING AN ESOPHAGEAL PROCEDURE, THE BRAVO CAPSULE DETACHED PRIOR TO THE END OF THE PROCEDURE. A REPEAT PROCEDURE WAS NECESSARY. NO OTHER KNOWN ADVERSE EVENTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
662612 BRAVO PH RECDR ELECTRODE, PH, STOMACH FFT GIVEN LTD (ISRAEL) FGS-0450 31516Q

Patients

Seq Age Sex Outcome Treatment
1